Literature DB >> 11524687

Molecular mechanism for dimerization to regulate the catalytic activity of human cytomegalovirus protease.

R Batra1, R Khayat, L Tong.   

Abstract

Biochemical studies indicate that dimerization is required for the catalytic activity of herpesvirus proteases, whereas structural studies show a complete active site in each monomer, away from the dimer interface. Here we report kinetic, biophysical and crystallographic characterizations of structure-based mutants in the dimer interface of human cytomegalovirus (HCMV) protease. Such mutations can produce a 1,700-fold reduction in the kcat while having minimal effects on the K(m). Dimer stability is not affected by these mutations, suggesting that dimerization itself is insufficient for activity. There are large changes in monomer conformation and dimer organization of the apo S225Y mutant enzyme. However, binding of an activated peptidomimetic inhibitor induced a conformation remarkably similar to the wild type protease. Our studies suggest that appropriate dimer formation may be required to indirectly stabilize the protease oxyanion hole, revealing a novel mechanism for dimerization to regulate enzyme activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11524687     DOI: 10.1038/nsb0901-810

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  18 in total

Review 1.  Allosteric regulation of protease activity by small molecules.

Authors:  Aimee Shen
Journal:  Mol Biosyst       Date:  2010-06-10

2.  Cytomegalovirus capsid protease: biological substrates are cleaved more efficiently by full-length enzyme (pUL80a) than by the catalytic domain (assemblin).

Authors:  Steve M Fernandes; Edward J Brignole; Kanchan Taori; Wade Gibson
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

3.  Novel yeast cell-based assay to screen for inhibitors of human cytomegalovirus protease in a high-throughput format.

Authors:  Valérie Cottier; Alcide Barberis; Urs Lüthi
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

4.  Substrate modulation of enzyme activity in the herpesvirus protease family.

Authors:  Ana Lazic; David H Goetz; Anson M Nomura; Alan B Marnett; Charles S Craik
Journal:  J Mol Biol       Date:  2007-08-16       Impact factor: 5.469

5.  Enzymatic activities of human cytomegalovirus maturational protease assemblin and its precursor (pPR, pUL80a) are comparable: [corrected] maximal activity of pPR requires self-interaction through its scaffolding domain.

Authors:  Edward J Brignole; Wade Gibson
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

Review 6.  Current and potential treatments for ubiquitous but neglected herpesvirus infections.

Authors:  Jonathan E Gable; Timothy M Acker; Charles S Craik
Journal:  Chem Rev       Date:  2014-10-02       Impact factor: 60.622

7.  Parkinson disease protein DJ-1 converts from a zymogen to a protease by carboxyl-terminal cleavage.

Authors:  Jue Chen; Lian Li; Lih-Shen Chin
Journal:  Hum Mol Genet       Date:  2010-03-18       Impact factor: 6.150

8.  Bimodal protein targeting through activation of cryptic mitochondrial targeting signals by an inducible cytosolic endoprotease.

Authors:  Ettickan Boopathi; Satish Srinivasan; Ji-Kang Fang; Narayan G Avadhani
Journal:  Mol Cell       Date:  2008-10-10       Impact factor: 17.970

9.  Inhibition of a viral enzyme by a small-molecule dimer disruptor.

Authors:  Tina Shahian; Gregory M Lee; Ana Lazic; Leggy A Arnold; Priya Velusamy; Christina M Roels; R Kiplin Guy; Charles S Craik
Journal:  Nat Chem Biol       Date:  2009-07-26       Impact factor: 15.040

10.  Communication between the active sites and dimer interface of a herpesvirus protease revealed by a transition-state inhibitor.

Authors:  Alan B Marnett; Anson M Nomura; Nobuhisa Shimba; Paul R Ortiz de Montellano; Charles S Craik
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.